What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Antigen, Molecular biology, Monoclonal antibody, Antibody and Immunology.
Her Antigen research is multidisciplinary, relying on both Pathology, Melanoma, Ganglioside, Cytotoxic T cell and Immunotherapy.
Her Molecular biology research includes elements of Cell, Computational biology, Peripheral blood and Cytotoxicity.
Ingegerd Hellström combines subjects such as Biochemistry, Binding site, Peptide sequence, Human melanoma and Epitope with her study of Monoclonal antibody.
Her work on Ganglioside GD3 as part of general Antibody research is frequently linked to Ceramide, bridging the gap between disciplines.
She works mostly in the field of Immunology, limiting it down to concerns involving In vitro and, occasionally, Transplantation, In vivo and Isoantigens.
Her most cited work include:
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 (1026 citations)
- Demonstration of cell-mediated immunity to human neoplasms of various histological types. (599 citations)
- Suggestive evidence that the 'blocking antibodies' of tumor-bearing individuals may be antigen-antibody complexes. (594 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Antigen, Molecular biology, Immunology, Antibody and Monoclonal antibody.
The various areas that Ingegerd Hellström examines in her Antigen study include Cancer research, Melanoma, In vitro, Monoclonal and Neoplasm.
Her Neoplasm research incorporates themes from Virus, Rickettsia, Virology, Serology and Transplantation.
Her Molecular biology research focuses on Spleen and how it connects with Lymph node.
In the field of Antibody, her study on Idiotype overlaps with subjects such as Conjugate.
Her study in Monoclonal antibody is interdisciplinary in nature, drawing from both Pathology, Biochemistry and Immunotherapy.
She most often published in these fields:
- Antigen (57.99%)
- Molecular biology (42.28%)
- Immunology (40.92%)
What were the highlights of her more recent work (between 1996-2020)?
- Cancer research (19.51%)
- Immunology (40.92%)
- Ovarian cancer (4.88%)
In recent papers she was focusing on the following fields of study:
Cancer research, Immunology, Ovarian cancer, Antibody and Antigen are her primary areas of study.
Her research integrates issues of Cisplatin, Immunosuppression, Monoclonal antibody, Antitumor activity and Immunotherapy in her study of Cancer research.
Her studies deal with areas such as Molecular biology, In vitro, Biochemistry and Autoimmunity as well as Monoclonal antibody.
Ingegerd Hellström interconnects Cytotoxic T cell, Carcinoma and Melanoma in the investigation of issues within Immunology.
Her Antibody study incorporates themes from Clinical efficacy and In vivo.
Her work blends Antigen and Conjugate studies together.
Between 1996 and 2020, her most popular works were:
- Potential markers that complement expression of CA125 in epithelial ovarian cancer (306 citations)
- Cutting edge: CD83 regulates the development of cellular immunity. (129 citations)
- Overexpression of HER-2 in ovarian carcinomas. (127 citations)
In her most recent research, the most cited papers focused on:
Ingegerd Hellström focuses on Pathology, Mesothelin, Ovarian carcinoma, Ovarian cancer and Carcinoma.
Her Pathology research integrates issues from Cancer, Adenocarcinoma, Antigen, Stage and Antibody.
Her work deals with themes such as Kallikrein and Osteopontin, which intersect with Antigen.
Ingegerd Hellström has researched Ovarian cancer in several fields, including Oncology, Peptide sequence, Fusion protein, Flow cytometry and Monoclonal antibody.
Her Monoclonal antibody research incorporates elements of Biological activity, In vitro, Potency and Biochemistry.
Her work is dedicated to discovering how Carcinoma, Immunology are connected with Carcinogenesis, Cervical cells, Cervical carcinoma and Genetic enhancement and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
